Abbott banks on glucose monitors, new launches to ride out China, currency hit
Abbott Laboratories on Wednesday forecast first-quarter profit below Wall Street as weakness in nutrition and diagnostics ...
Larry Magid: Testing prescription, over-the-counter continuous glucose monitors
A few weeks ago, an allergist prescribed a two-week course of an oral steroid to clear up my sinus inflammation. Before I ...
drugdeliverybusiness7d
Abbott Diabetes spurs growth with 22.7% uptick in CGM revenue, expects more insulin pump connectivity
Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.
Future Market Insights2d
Global Lancet Market Set for Robust Growth, Projected to Reach USD 3.7 Billion by 2033
With a solid foundation for growth and a promising outlook, the global lancet market is on track to achieve its projected USD ...
MassDevice7d
Abbott sales come up just shy of Q4 expectations on Wall Street, highlights EP growth
Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...
The Gazette8d
Abbott banks on glucose monitors, new launches to ride out China, currency hit
which makes medical devices and also sells nutrition products such as baby formula, has seen a large boost to sales from strong demand for FreeStyle Libre - its continuous glucose monitor.